Engineering Defined Bacterial Consortia for Therapeutics Based on Trophic Interactions | Kisaco Research

Engineering Defined Bacterial Consortia for Therapeutics Based on Trophic Interactions

  • PharmaBiome's NicheMap™ technology maps bacteria into functional niches taking into account the relevant complex context of intestinal microbiota
  • The NicheMap™ provides an evidence-based selection rationale for strains that make up out metabolically interacting LBP consortia
  • We produce these ecologically engineered consortia using cocultivation with PharmaBiome's C3 technology
  • The NicheMap™ and C3 produce consortia with strong control over pharmacokinetics and pharmacodynamics
Speaker(s): 

Author:

Gabriel Leventhal

CSO
PharmaBiome
... read more

Gabriel Leventhal

CSO
PharmaBiome